A portable surgical robot developed by a Cambridge-based company has been approved by US regulators.
In a breakthrough for CMR Surgical in the world’s biggest healthcare market, the company said America’s Food and Drug Administration had granted marketing authorisation for its Versius Surgical System.
The green light, a decade after the company was founded, means CMR Surgical can now prepare to sell Versius in the US for use for adult patients 22 years old and above for gallbladder removal surgery.
Versius, designed to biomimic the human arm and assist surgeons, is already the world’s second-most utilised surgical robotic system, with 26,000 surgical cases completed, including in the UK.
CMR Surgical was founded in 2014 and remains based in Cambridge where it also has a manufacturing site. It is backed by international investors including SoftBank.
Date: 22 October